Home / Knowledge Centre /
Webinar

Bioavailability Enhancement: Integrated Solutions from Early Development to GMP Manufacture

In this webinar hosted by CPHI, Jonathan Loughrey, Director of Chemical Development, Almac Pharma Services, and Terry Ernest, Director of Manufacturing Science & Technology, Almac Pharma Services, discuss how Integrated Bioavailability Strategies can accelerate development and support successful GMP manufacture.

This expert‑led webinar explores:

  • Practical approaches to bioavailability enhancement
  • How to align early development decisions with GMP requirements
  • Integrated solutions that reduce risk and improve outcomes

Click below or watch this webinar on-demand: CPHI x Almac – Bioavailability Enhancement Webinar

View Resource

Our Experts

Expert name: Jonathan Loughrey Jonathan Loughrey, Associate Director of Physical Sciences and Isotope Chemistry, Craigavon, Almac API, Chemical Development & Analytical Services
Expert name: Terry Ernest Terry Ernest, Director, Manufacturing Science and Technology, Charnwood, Almac Pharmaceutical Development

Please complete this form to view the Webinar

You may also be interested in

Bioavailability Enhancement: Integrated Solutions from Early Development to GMP Manufacture
Webinar

Bioavailability Enhancement: Integrated Solutions from Early Development to GMP Manufacture

Expert name: Jonathan Loughrey
Expert name: Terry Ernest
From Lab to Patient: The Importance of Stability Studies
Blog

From Lab to Patient: The Importance of Stability Studies

Stay up-to-date with the latest from Almac

Join our mailing list
This website uses cookies. By continuing to browse the site, you are agreeing to our use of cookies